These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15709881)

  • 1. Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.
    Toussirot E; Wendling D
    Expert Opin Pharmacother; 2005 Jan; 6(1):35-43. PubMed ID: 15709881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis.
    Toussirot E; Wendling D
    Curr Opin Rheumatol; 2007 Jul; 19(4):340-5. PubMed ID: 17551363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.
    Santra G; Sarkar RN; Phaujdar S; Banerjee S; Siddhanta S
    Singapore Med J; 2010 Nov; 51(11):883-7. PubMed ID: 21140116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis.
    De Keyser F; Baeten D; Van den Bosch F; Kruithof E; Verbruggen G; Mielants H; Veys E
    Drugs; 2004; 64(24):2793-811. PubMed ID: 15563249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the treatment of the spondyloarthropathies.
    Liu Y; Cortinovis D; Stone MA
    Curr Opin Rheumatol; 2004 Jul; 16(4):357-65. PubMed ID: 15201597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in ankylosing spondylitis treatment.
    Toussirot E; Wendling D
    Expert Opin Pharmacother; 2003 Jan; 4(1):1-12. PubMed ID: 12517239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort.
    Poddubnyy D; Haibel H; Braun J; Rudwaleit M; Sieper J
    Arthritis Rheumatol; 2015 Sep; 67(9):2369-75. PubMed ID: 26017497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New evidence on the management of spondyloarthritis.
    Sieper J; Poddubnyy D
    Nat Rev Rheumatol; 2016 May; 12(5):282-95. PubMed ID: 27052489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment of ankylosing spondylitis: a systematic review.
    Boulos P; Dougados M; Macleod SM; Hunsche E
    Drugs; 2005; 65(15):2111-27. PubMed ID: 16225367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spondylarthropathies and anti-TNFalpha drugs].
    Pavy S; Allanore Y; Kahan A
    Rev Med Interne; 2005 Sep; 26(9):717-24. PubMed ID: 16154026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of spondyloarthropathy: the potential for agents other than TNF inhibitors.
    Her M; Kavanaugh A
    Curr Opin Rheumatol; 2013 Jul; 25(4):455-9. PubMed ID: 23680779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-TNF alfa therapy in ankylosing spondylitis].
    Cravo AR; Tavares V; Da Silva JC
    Acta Med Port; 2006; 19(2):141-50. PubMed ID: 17187716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New treatment targets for axial spondyloarthritis.
    Sieper J
    Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii38-ii42. PubMed ID: 27856659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spondylarthropathies: options for combination therapy.
    van Tubergen AM; Landewé RB; van der Linden S
    Springer Semin Immunopathol; 2001; 23(1-2):147-63. PubMed ID: 11455853
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic advances in ankylosing spondylitis.
    Toussirot E; Wendling D
    Expert Opin Investig Drugs; 2001 Jan; 10(1):21-9. PubMed ID: 11116278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are there new emerging drugs for ankylosing spondylitis or spondyloarthritis?
    Wendling D
    Expert Opin Emerg Drugs; 2013 Mar; 18(1):5-7. PubMed ID: 23216081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab for the treatment of ankylosing spondylitis.
    Sieper J; Rudwaleit M; Braun J
    Expert Opin Pharmacother; 2007 Apr; 8(6):831-8. PubMed ID: 17425478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset ankylosing spondylitis and related spondylarthropathies: clinical and radiological characteristics and pharmacological treatment options.
    Toussirot E; Wendling D
    Drugs Aging; 2005; 22(6):451-69. PubMed ID: 15974637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spondylarthropathies: conventional treatments and anti-TNF].
    Dumusc A; So A
    Rev Med Suisse; 2016 Mar; 12(509):507-8, 510-1. PubMed ID: 27089640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new strategy of drug treatment in NSAID--unresponsive ankylosing spondylitis.
    Chogle AR; Mishra H; Chakravarty A
    J Assoc Physicians India; 2007 May; 55():380; author reply 380-1. PubMed ID: 17844703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.